http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109999011-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
filingDate | 2019-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109999011-B |
titleOfInvention | Clarithromycin sustained-release capsule and preparation method thereof |
abstract | The invention discloses a clarithromycin sustained-release capsule which is prepared by filling double-layer coated pill cores into the capsule according to dosage; the double-layer coated pill core comprises a medicine-containing pill core, an isolating layer and an enteric-coated layer. Wherein the pill core containing medicine contains magnesium aluminum silicate. The application of the magnesium aluminum silicate with specific content and the specific double-layer coating leads the chemical stability of the clarithromycin sustained-release capsule in gastric juice to be obviously improved, and the sustained-release effect can be better embodied in the gastric juice, thereby further improving the bioavailability. |
priorityDate | 2019-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.